 |
The Journal of Neuroscience, June 1, 2005, 25(22):5376-5381; doi:10.1523/JNEUROSCI.0766-05.2005
Previous Article | Next Article 
BRIEF COMMUNICATION
DNA Methylation Status of SOX10 Correlates with Its Downregulation and Oligodendrocyte Dysfunction in Schizophrenia
Kazuya Iwamoto,1
Miki Bundo,1
Kazuo Yamada,2
Hitomi Takao,2
Yoshimi Iwayama-Shigeno,2
Takeo Yoshikawa,2 and
Tadafumi Kato1
1Laboratory for Molecular Dynamics of Mental Disorders, and 2Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama 351-0198, Japan
Downregulation of oligodendrocyte-related genes, referred to as oligodendrocyte dysfunction, in schizophrenia has been revealed by DNA microarray studies. Because oligodendrocyte-specific transcription factors regulate the differentiation of oligodendrocytes, genes encoding them are prime candidates for oligodendrocyte dysfunction in schizophrenia. We found that the cytosine-guanine dinucleotide (CpG) island of sex-determining region Y-box containing gene 10 (SOX10), an oligodendrocyte-specific transcription factor, tended to be highly methylated in brains of patients with schizophrenia, correlated with reduced expression of SOX10. We also found that DNA methylation status of SOX10 also was associated with other oligodendrocyte gene expressions in schizophrenia. This may be specific to SOX10, because the CpG island of OLIG2, which encodes another oligodendrocyte-specific transcription factor, was rarely methylated in brains, and the methylation status of myelin-associated oligodendrocytic basic protein, which encodes structural protein in oligodendrocytes, did not account for their expressions or other oligodendrocyte gene expressions. Therefore, DNA methylation status of the SOX10 CpG island could be an epigenetic sign of oligodendrocyte dysfunction in schizophrenia.
Key words: oligodendrocyte; postmortem; schizophrenia; DNA methylation; epigenetics; SOX10
Received Feb 25, 2005;
revised April 18, 2005;
accepted April 26, 2005.
This article has been cited by other articles:

|
 |

|
 |
 
J. S. Brown Jr
Effects of Bisphenol-A and Other Endocrine Disruptors Compared With Abnormalities of Schizophrenia: An Endocrine-Disruption Theory of Schizophrenia
Schizophr Bull,
January 31, 2008;
(2008)
sbm147v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Aydin, A. Ucok, and S. Cakir
Quantitative Proton MR Spectroscopy Findings in the Corpus Callosum of Patients with Schizophrenia Suggest Callosal Disconnection
AJNR Am. J. Neuroradiol.,
November 1, 2007;
28(10):
1968 - 1974.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Georgieva, V. Moskvina, T. Peirce, N. Norton, N. J. Bray, L. Jones, P. Holmans, S. MacGregor, S. Zammit, J. Wilkinson, et al.
Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia
PNAS,
August 15, 2006;
103(33):
12469 - 12474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Iwamoto and T. Kato
Gene Expression Profiling in Schizophrenia and Related Mental Disorders
Neuroscientist,
August 1, 2006;
12(4):
349 - 361.
[Abstract]
[PDF]
|
 |
|
|